REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioprocesos Biolabs Cia. Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bioprocesos Biolabs Cia. Ltda Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioprocesos Biolabs Cia. Ltda is a company in Ecuador, with a head office in Sangolqui. The company operates in the Pharmaceutical and Medicine Manufacturing industry. Bioprocesos Biolabs Cia. Ltda was incorporated on October 12, 2020. Bioprocesos Biolabs Cia. Ltda currently employs 4 (2023) people. From the latest financial highlights, Bioprocesos Biolabs Cia. Ltda reported a net sales revenue increase of 162.38% in 2023. During that time, Bioprocesos Biolabs Cia. Ltda’s total assets decreased by 1.99%. The net profit margin of Bioprocesos Biolabs Cia. Ltda increased by 4.63% in 2023.

Headquarters
Calle Puruhaes, Lote 44
Sangolqui; Pichincha;

Contact Details: Purchase the Bioprocesos Biolabs Cia. Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Bioprocesos Biolabs Cia. Ltda report to view the information.
Outstanding Shares:
Purchase the Bioprocesos Biolabs Cia. Ltda report to view the information.
Registered Capital:
Purchase the Bioprocesos Biolabs Cia. Ltda report to view the information.
Incorporation Date:
October 12, 2020
Key Executives
Purchase this report to view the information.
President
Company Performance
Financial values in the chart are available after Bioprocesos Biolabs Cia. Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
162.38%▲
Total operating revenue
162.38%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
1304.15%▲
Total assets
-1.99%▼
Total equity
103.04%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
4.63%▲
Return on Equity (ROE)
41.89%▲
Quick Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo